European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact
Guidelines

Non-neurogenic Female LUTS

Want to read the guideline in your own time? Download the PDF

Download full guideline

Looking for a quick overview? Check the pocket guidelines.

Download pocket guidelines
Full text guidelineSummary of ChangesPublications & AppendicesPanelRelated content
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
2025
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • No elements found. Consider changing the search query.
  • List is empty.

For the 2025 Non-neurogenic Female LUTS Guidelines new and relevant evidence was identified, collated and appraised through a structured assessment of the literature for all sections of the guidelines. Key changes include:

  • A new summary of evidence (SOE) in section 3.71 for pad tests.
  • New SOE and recommendations in section 4.1.4.1.2.1 for conservative management of OAB.
  • Summarized text in section 4.1.4.1.3 and an additional SOE with regards to urinary containment.
  • New SOE and recommendation in section 4.1.4.1.5.5 for behavioural and physical therapies.
  • A new recommendation for anticholinergic drugs in section 4.1.4.2.1.4.
  • A new section 4.1.4.2.6 on Saw palmetto extract.
  • A new SOE for detrusor myomectomy in section 4.1.4.3.4.4.
  • A new SOE for pelvic floor muscle training in section 4.2.4.1.3.7.
  • A new SOE and recommendations for electromagnetic stimulation and electroacupuncture in section 4.2.4.1.6.
  • A new recommendation in section 4.2.4.3.2.5.1 for mid-urethral slings and in section 4.2.4.3.2.6.1 for treatment of stress urinary incontinence.
  • A new section 4.3.3.3.2 on Mirabegron as well as a new SOE.
  • A new SOE in section 4.5.5.2.3.3 for surgical management of functional bladder out let obstruction.
  • Extensive update on the pharmacological management of Nocturia, including new SOE in section 4.6.4.3.
  • A new SOE and recommendation for detection of SUI in women with POP, in section 4.7.3.2.
  • A new recommendation for the classification of urinary fistula in section 4.8.2.1
About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer